GE

Unknown

905 clinical trials

Find Trials

Clinical Trials (905)

Showing 20 of 905 trialsScroll for more
NCT06667700Phase 38 sites

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Recruiting
NCT06323928Phase 28 sites

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

Completed
NCT07378644Phase 22 sites

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

Recruiting
NCT06940154Phase 26 sites

Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

Recruiting
NCT06471829Phase 24 sites

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

Recruiting
NCT07091630Phase 38 sites

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Recruiting
NCT06641089Phase 36 sites

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Recruiting
NCT06430801Phase 34 sites

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT06641076Phase 39 sites

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Active Not Recruiting
NCT06940141Phase 26 sites

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

Recruiting
NCT03073967Phase 32 sites

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Completed
NCT05979441Phase 34 sites

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Enrolling By Invitation
NCT06637631Phase 27 sites

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Recruiting
NCT06238622Phase 33 sites

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Recruiting
NCT06806852Phase 11 site

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Active Not Recruiting
NCT06980116Phase 11 site

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Recruiting
NCT06632444Phase 32 sites

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Recruiting
NCT06619990Phase 11 site

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Recruiting
NCT06632457Phase 32 sites

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting
NCT07280156Phase 26 sites

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

Recruiting